We believe that consecutive immunization with antigenically distinct influenza viruses within the same subtype, or with closely related subtypes, can induce broadly-neutralizing antibodies against the viral HA. Using this concept and the pig model of influenza, we will develop vaccination strategies that can protect swine and humans against any H1N1 virus clade, as well as potentially pandemic avian H5 viruses.